Research News for 2007
-
Arimidex More Effective Than Tamoxifen for Postmenopausal Women
Another year of results from the ATAC trial continues to show that Arimidex has more benefits than tamoxifen for post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.
-
Genetic Test Can Predict Recurrence Risk, Help Make Treatment Decisions
The Oncotype DX test can help determine who will benefit from hormonal therapy plus chemotherapy, as opposed to hormonal therapy alone, in post-menopausal women diagnosed with estrogen-receptor-positive, node-positive breast cancer.
-
Taxotere Combo Improves Survival
The combination of Taxotere (chemical name: docetaxel) and Cytoxan (chemical name: cyclophosphamide) offers better survival and fewer and less severe side effects than the combination of Adriamycin (chemical name: doxorubicin) and Cytoxan for treating breast cancer.
-
Controlling Insulin Levels Key for Diagnosed Women
A new study suggests that lower insulin levels can help improve breast cancer survival.
-
Radiologists Interpret Mammograms Differently
The ability of radiologists to accurately read diagnostic mammograms varies widely and radiologists who work at academic medical centers are likely to be more accurate than non-medical center radiologists.
-
Postmenopausal Women Benefit from Longer Hormonal Therapy
Taking Arimidex for 3 years after 5 years of tamoxifen reduced the risk of the cancer coming back in women diagnosed with hormone-receptor-positive breast cancer.
-
Research Reveals Abnormal BRCA1 Gene’s Cancer-Causing Ability
Researchers seem to have figured out how abnormal BRCA1 genes lead to breast cancer.
-
Gaining Weight After Diagnosis Decreases Survival
Women who gain weight after being diagnosed with breast cancer have a worse prognosis than women who don't gain weight.
-
Plasticizing Chemical Seems to Increase Risk
A common chemical used in many household products may raise breast cancer risk in rats, which may have implications for people.
-
Experts Say No to Avastin for Breast Cancer
An FDA expert panel recommended that Avastin not be used to treat advanced breast cancer. But doctors may still recommend the medicine depending on a woman's unique situation.
